Figure 2.
For patients who received vincristine, median survival was 85.3 months (95% CI: 20.2–85.3). For patients who did not receive vincristine, median survival was 67.1 months (95% CI: 10.5–NR, upper bound not reached).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.